Skip to main content

Day: May 7, 2025

Cognition Therapeutics Reports Financial Results for the First Quarter 2025 and Provides Business Update

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

– End-of-Phase 2 meeting with FDA requested for Alzheimer’s disease – – Phase 2 results in dementia with Lewy bodies accepted for oral presentation at AAIC – – Two posters at ARVO describe zervimesine’s role supporting retinal cell health – PURCHASE, N.Y., May 07, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, today reported financial results for the first quarter ended March 31, 2025, and provided a business update. “During our first quarter of 2025 and in recent weeks, we continued to advance our Alzheimer’s disease and dementia with Lewy bodies (DLB) programs,” stated Lisa Ricciardi, Cognition’s president and CEO. “A request was made with the U.S. Food...

Continue reading

MasterCraft Boat Holdings, Inc. Reports Fiscal 2025 Third Quarter Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

VONORE, Tenn., May 07, 2025 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2025 third quarter ended March 30, 2025. The overview, commentary, and results provided herein relate to our continuing operations, which exclude our former Aviara segment. Overview:Net sales for the third quarter were $76.0 million, down $8.0 million, or 9.5%, from the comparable prior-year period Planned decrease in production contributed to approximately 30% lower dealer inventory levels compared to the prior-year Income from continuing operations was $3.8 million, or $0.23 per diluted share Adjusted Net Income, a non-GAAP measure, was $5.0 million, or $0.30 per diluted share Adjusted EBITDA, a non-GAAP measure, was $7.5 million, down $4.2 million from the comparable prior-year period Cash...

Continue reading

Amerigo Announces Q1-2025 Results & Quarterly Dividend

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Q1-2025 Net Income of $3.3 million Robust EBITDA1 of $15.2 million and Free Cash Flow to Equity1 of $4.8 million 15th Quarterly Dividend of Cdn$.03 Declared $4.6 million Returned through Dividends and Share Buybacks in Q1-2025 VANCOUVER, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce a strong financial performance for the three months ended March 31, 2025 (“Q1-2025”). Dollar amounts in this news release are in U.S. dollars unless indicated otherwise. Amerigo’s Q1-2025 financial results included net income of $3.3 million, earnings per share (“EPS”) of $0.02, EBITDA1   of $15.2 million, operating cash flow from operations before changes in non-cash working capital1 of $11.6 million and free cash flow to equity1 of $4.8 million....

Continue reading

InflaRx Reports First Quarter 2025 Financial Results and Provides Business Update

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Announces successful completion of sub-chronic and chronic toxicology studies for INF904, supporting long-term dosing in future clinical trials Multiple near-term catalysts anticipated with the potential to substantially de-risk the Company’s pipeline addressing multiple sizable markets Interim analysis for vilobelimab Phase 3 trial in pyoderma gangrenosum (PG), to determine trial size adaptation or futility, remains on schedule with a recommendation expected to be announced at the end of May to early June Topline data for INF904 Phase 2a trial in chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) expected in summer 2025 Cash, cash equivalents and marketable securities totaled €65.7 million on March 31, 2025, including proceeds from our underwritten public offering completed in February Company estimates it has...

Continue reading

Costamare Inc. Announces Completion of the Costamare Bulkers Holdings Limited Spin-Off

Written by Customer Service on . Posted in Public Companies.

MONACO , May 07, 2025 (GLOBE NEWSWIRE) — Costamare Inc. (NYSE:CMRE) (the “Company”) announced today that it has completed the spin-off of its dry bulk business into a standalone public company, Costamare Bulkers Holdings Limited (“Costamare Bulkers”). Each holder of Costamare Inc. common shares received one common share of Costamare Bulkers Holdings Limited for every five Costamare Inc. common shares held as of the close of business on April 29, 2025. The successful execution of the Costamare Bulkers spin-off transforms Costamare Inc. into a predominantly global container shipping provider, while still maintaining its presence in Neptune Maritime Leasing. Costamare Bulkers shares will be listed and commence trading today on the NYSE under the ticker symbol “CMDB” from 9:30 a.m., New York City time. Costamare Inc. will continue...

Continue reading

Costamare Bulkers Holdings Limited Debuts as Independent, Publicly Traded Company

Written by Customer Service on . Posted in Public Companies.

Company completes separation from Costamare Inc. Begins trading today on NYSEMONACO, May 07, 2025 (GLOBE NEWSWIRE) — Costamare Bulkers Holdings Limited (NYSE:CMDB) (“Costamare Bulkers” or the “Company”) announced today its debut as an independent, publicly traded company and the completion of its separation from Costamare Inc. The Company’s shares begin trading today from 9:30 a.m., New York City time on the New York Stock Exchange (the “NYSE”) under the symbol “CMDB.” Costamare Inc. will continue to trade on the NYSE under the ticker symbol “CMRE.” Under the terms of the separation, each holder of Costamare Inc. common shares received one common share of Costamare Bulkers for every five Costamare Inc. common shares held as of the close of business on April 29, 2025. Following the successful execution of the spin-off, the Company...

Continue reading

Sunrise Realty Trust, Inc. Announces Financial Results for the First Quarter 2025

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

First quarter 2025 GAAP net income of $3.1 million or $0.27 per basic weighted average common share and Distributable Earnings(1) of $3.5 million or $0.31 per basic weighted average common share WEST PALM BEACH, Fla., May 07, 2025 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (NASDAQ:SUNS) (“SUNS” or the “Company”) today announced its results for the quarter ended March 31, 2025. SUNS reported generally accepted accounting principles (“GAAP”) net income of $3.1 million or $0.27 per basic weighted average common share and Distributable Earnings of $3.5 million or $0.31 per basic weighted average common share for the first quarter of 2025. Brian Sedrish, Chief Executive Officer, said, “SUNS entered 2025 with a strong balance sheet and a portfolio comprised of recently originated, performing loans, enabling the Company to continue...

Continue reading

BridgeBio to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 2025

Written by Customer Service on . Posted in Public Companies.

PALO ALTO, Calif., May 07, 2025 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will participate in a fireside chat at the Bank of America Merrill Lynch Global Healthcare Conference 2025 in Las Vegas, NV on Wednesday, May 14 at 2:20 pm PT. To access the live webcast of BridgeBio’s presentation, please visit the “Events” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcast will be available on the BridgeBio website for 30 days following the event. About BridgeBio Pharma, Inc.BridgeBio Pharma, Inc. (BridgeBio) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative...

Continue reading

250 MW/1,000 MWh Oneida Energy Storage Project Commences Commercial Operations

Written by Customer Service on . Posted in Public Companies.

Provides Ontario with critical capacity as Canada’s largest grid-scale battery energy storage facility in operationOneida Battery Energy Storage Project, April 2025 TORONTO, May 07, 2025 (GLOBE NEWSWIRE) — The Oneida Energy Storage Project (“Oneida”) has officially entered commercial operations, becoming the largest battery energy storage facility in operations in Canada, and one of the largest globally. Located in Haldimand County, Ontario, the 250 MW / 1,000 MWh facility was delivered ahead of schedule and under budget through a collaborative partnership between majority owner Northland Power Inc. (Northland), Six Nations of the Grand River Development Corporation (SNGRDC), NRStor Inc., Aecon Concessions, and the Mississaugas of the Credit Business Corporation (MCBC). Together, they form the Oneida Energy Storage Limited Partnership...

Continue reading

YY Group Holding Limited Announces Global Expansion Across Europe, Middle East, North Africa, and Asia-Pacific

Written by Customer Service on . Posted in Mergers And Acquisitions.

Singapore, May 07, 2025 (GLOBE NEWSWIRE) — YY Group Holding Limited (NASDAQ: YYGH) (“YY Group,” “YYGH,” or the “Company”) is thrilled to announce a significant milestone as its flagship on-demand job matching platform, YY Circle, continues to expand its footprint, meeting the surging global demand for innovative workforce solutions. Driving Innovation Across Europe In Europe, YY Circle is making significant strides:YY Circle UK, based in London, is gaining momentum, serving an impressive portfolio of clients and solidifying its position as a trusted partner for businesses in the region. YY Circle Netherlands is on track to go live by the end of this May, marking a pivotal step in expanding YY Circle’s presence in Northern Europe. YY Circle Germany is poised to launch within 6 to 8 weeks, reinforcing YY Group’s commitment to delivering...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.